InvestorsHub Logo
icon url

lasers

05/29/17 4:56 PM

#258759 RE: Jimmy Joe #258750

For those that need Trimipramine, the benefits outweigh any side effects.

The problem is persons needing this specific tricyclic antidepressant Trimipramine do not respond to any of the newer antidepressants such as Tetracyclic antidepressants (TeCAs), nor antidepressants such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs) and norepinephrine reuptake inhibitors (NRIs).

Therefore the FDA continues to need for Trimipramine to be available for prescription needs. Therefore the FDA is very thankful to both $ELTP as the new owner and Dr Reddys as the Marketer/Distributor.
icon url

namtae

05/29/17 7:08 PM

#258765 RE: Jimmy Joe #258750

Lets see, it has an extremely limited market due to among other things, its extremely dangerous.

So nasrat, being the good guy that he is, unloaded it on Elite for $1.2m???

He did this great favor to Elite for what again? Oh right, so the FDA would adore them and approve Sequest..

Yea, that must be it (rofl)